Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cognitive behavior therapy and fluoxetine for troublesome supragastric belching
TCTR20210122006Phase 3Recruiting
- Sponsor
- na
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fluoxetine in supragastric belching (SGB), sponsored by na. Started Feb 2021; status: recruiting.
02
Drugs
fluoxetine
03
Conditions
supragastric belching (SGB)
Beyond the preview
Go deeper on TCTR20210122006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210122006.